npj Parkinson's Disease (Mar 2024)

A multi-site study on sex differences in cortical thickness in non-demented Parkinson’s disease

  • Javier Oltra,
  • Barbara Segura,
  • Antonio P. Strafella,
  • Thilo van Eimeren,
  • Naroa Ibarretxe-Bilbao,
  • Maria Diez-Cirarda,
  • Carsten Eggers,
  • Olaia Lucas-Jiménez,
  • Gemma C. Monté-Rubio,
  • Natalia Ojeda,
  • Javier Peña,
  • Marina C. Ruppert,
  • Roser Sala-Llonch,
  • Hendrik Theis,
  • Carme Uribe,
  • Carme Junque

DOI
https://doi.org/10.1038/s41531-024-00686-2
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Clinical, cognitive, and atrophy characteristics depending on sex have been previously reported in Parkinson’s disease (PD). However, though sex differences in cortical gray matter measures in early drug naïve patients have been described, little is known about differences in cortical thickness (CTh) as the disease advances. Our multi-site sample comprised 211 non-demented PD patients (64.45% males; mean age 65.58 ± 8.44 years old; mean disease duration 6.42 ± 5.11 years) and 86 healthy controls (50% males; mean age 65.49 ± 9.33 years old) with available T1-weighted 3 T MRI data from four international research centers. Sex differences in regional mean CTh estimations were analyzed using generalized linear models. The relation of CTh in regions showing sex differences with age, disease duration, and age of onset was examined through multiple linear regression. PD males showed thinner cortex than PD females in six frontal (bilateral caudal middle frontal, bilateral superior frontal, left precentral and right pars orbitalis), three parietal (bilateral inferior parietal and left supramarginal), and one limbic region (right posterior cingulate). In PD males, lower CTh values in nine out of ten regions were associated with longer disease duration and older age, whereas in PD females, lower CTh was associated with older age but with longer disease duration only in one region. Overall, male patients show a more widespread pattern of reduced CTh compared with female patients. Disease duration seems more relevant to explain reduced CTh in male patients, suggesting worse prognostic over time. Further studies should explore sex-specific cortical atrophy trajectories using large longitudinal multi-site data.